MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
DE69419523T2
(de)
*
|
1993-11-22 |
1999-11-25 |
Upjohn Co |
Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
CN1046520C
(zh)
*
|
1994-11-15 |
1999-11-17 |
法玛西雅厄普约翰美国公司 |
二环噁嗪及噻嗪噁唑烷酮抗菌剂
|
ATE205205T1
(de)
*
|
1995-02-03 |
2001-09-15 |
Upjohn Co |
Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
|
ES2162047T3
(es)
*
|
1995-05-11 |
2001-12-16 |
Upjohn Co |
Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico.
|
CA2228647A1
(en)
*
|
1995-09-01 |
1997-03-13 |
Pharmacia & Upjohn Company |
Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
|
MX9703040A
(es)
*
|
1995-09-12 |
1997-07-31 |
Upjohn Co |
Antimicrobianos de feniloxazolidinona.
|
AU6964096A
(en)
*
|
1995-09-15 |
1997-04-01 |
Pharmacia & Upjohn Company |
Aminoaryl oxazolidinone n-oxides
|
ZA968661B
(en)
*
|
1995-11-17 |
1998-04-14 |
Upjohn Co |
Oxazolidinone antibacterial agent with tricyclic substituents.
|
ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
SK284703B6
(sk)
*
|
1996-04-11 |
2005-09-08 |
Pharmacia & Upjohn Company |
Spôsob prípravy substituovaných oxazolidinón alkoholov
|
AT403803B
(de)
|
1996-04-19 |
1998-05-25 |
Sanochemia Ltd |
Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9614238D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
GB9614236D0
(en)
*
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
KR100307211B1
(ko)
*
|
1997-05-24 |
2001-11-30 |
손 경 식 |
옥사졸리디논유도체,이의제조방법및그를함유한항균제조성물
|
US6037354A
(en)
|
1997-06-18 |
2000-03-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
CN1211384C
(zh)
*
|
1997-07-11 |
2005-07-20 |
法玛西雅厄普约翰美国公司 |
噻二唑基和噁二唑基苯基噁唑烷酮抗菌剂
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
KR100467309B1
(ko)
*
|
1997-09-04 |
2005-07-18 |
씨제이 주식회사 |
옥사졸리디논유도체및그의제조방법및항균제조성물
|
KR100463111B1
(ko)
*
|
1997-10-30 |
2005-06-13 |
씨제이 주식회사 |
신규한옥사졸리디논유도체및제조방법및그를함유하는항균제조성물
|
CA2304100A1
(en)
|
1997-11-07 |
1999-05-20 |
Pharmacia & Upjohn Company |
Process to produce oxazolidinones
|
AU739055B2
(en)
*
|
1997-11-12 |
2001-10-04 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
AU780197B2
(en)
*
|
1997-11-18 |
2005-03-10 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
ATE299021T1
(de)
*
|
1997-11-18 |
2005-07-15 |
Pharmacia & Upjohn Co Llc |
Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
|
CN1546030A
(zh)
*
|
1997-11-18 |
2004-11-17 |
�������Ŷ���Լ��������˾ |
噁唑烷酮衍生物在治疗关节炎和减少癌症化学疗法毒性中的应用
|
US6040306A
(en)
*
|
1997-11-18 |
2000-03-21 |
Pharmacia & Upjohn Company |
Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
KR20010015910A
(ko)
|
1998-01-23 |
2001-02-26 |
로렌스 티. 마이젠헬더 |
옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
ES2182485T3
(es)
*
|
1998-02-13 |
2003-03-01 |
Upjohn Co |
Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.
|
EP1082323A2
(en)
*
|
1998-06-05 |
2001-03-14 |
AstraZeneca UK Limited |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9812019D0
(en)
*
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
JP3390744B2
(ja)
*
|
1998-09-22 |
2003-03-31 |
山之内製薬株式会社 |
シアノフェニル誘導体
|
CN1322204A
(zh)
*
|
1998-11-27 |
2001-11-14 |
法玛西雅厄普约翰美国公司 |
具有硫代羰基官能团的噁唑烷酮抗菌剂
|
WO2000045177A1
(en)
|
1999-01-27 |
2000-08-03 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
JP2003513885A
(ja)
|
1999-07-28 |
2003-04-15 |
ファルマシア・アンド・アップジョン・カンパニー |
オキサゾリジノンおよび抗感染薬としてのその使用
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
AR027261A1
(es)
*
|
2000-02-02 |
2003-03-19 |
Upjohn Co |
Linezolid forma cristalina ii
|
US6642238B2
(en)
|
2000-02-10 |
2003-11-04 |
Pharmacia And Upjohn Company |
Oxazolidinone thioamides with piperazine amide substituents
|
MY127336A
(en)
*
|
2000-03-22 |
2006-11-30 |
Upjohn Co |
Container for linezolid iv solution
|
US6514529B2
(en)
*
|
2000-03-22 |
2003-02-04 |
Pharmacia & Upjohn Company |
Oxazolidinone tablet formulation
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
HUP0301562A2
(hu)
|
2000-06-05 |
2003-12-29 |
Dong A Pharm. Co., Ltd. |
Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények
|
DK1301207T3
(da)
|
2000-06-30 |
2005-10-10 |
Pharmacia & Upjohn Co Llc |
Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
|
SK1402003A3
(en)
|
2000-07-17 |
2003-08-05 |
Ranbaxy Lab Ltd |
Oxazolidinone derivatives as antimicrobials
|
JP4170753B2
(ja)
|
2000-10-17 |
2008-10-22 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
オキサゾリジノン化合物の製造方法
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
ES2186550B2
(es)
*
|
2001-06-27 |
2003-11-16 |
Vita Lab |
Nuevos derivados de oxazolidinonas como antibacterianos.
|
EP1409464A4
(en)
*
|
2001-07-16 |
2005-11-02 |
Ranbaxy Lab Ltd |
OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
RU2004111285A
(ru)
*
|
2001-09-11 |
2005-10-10 |
Астразенека Аб (Se) |
Оксазолидинон и/или изоксазолин в качестве антибактериальных средств
|
WO2003035073A1
(en)
|
2001-10-25 |
2003-05-01 |
Astrazeneca Ab |
Isoxazoline derivatives useful as antimicrobials
|
WO2003035648A1
(en)
*
|
2001-10-25 |
2003-05-01 |
Astrazeneca Ab |
Aryl substituted oxazolidinones with antibacterial activity
|
TW200302095A
(en)
*
|
2002-01-25 |
2003-08-01 |
Upjohn Co |
Oxazolidinone cotherapy
|
CA2475036A1
(en)
*
|
2002-02-05 |
2003-08-14 |
Gary W. Luehr |
Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
|
US7141588B2
(en)
*
|
2002-02-25 |
2006-11-28 |
Pfizer, Inc. |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
AR038536A1
(es)
*
|
2002-02-25 |
2005-01-19 |
Upjohn Co |
N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
|
PL372661A1
(en)
*
|
2002-03-29 |
2005-07-25 |
Pharmacia & Upjohn Company Llc. |
Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
|
EA200401289A1
(ru)
*
|
2002-04-01 |
2005-04-28 |
Кадила Хелзкэр Лимитед |
Новые противоинфекционные соединения, способы их получения и фармацевтические композиции, содержащие эти соединения
|
JP2005529924A
(ja)
*
|
2002-05-15 |
2005-10-06 |
ランバクシー ラボラトリーズ リミテッド |
フェニルオキサゾリジノン誘導体
|
MXPA05001199A
(es)
*
|
2002-07-29 |
2005-05-16 |
Ranbaxy Lab Ltd |
Derivados de oxazolidinona como antimicrobianos.
|
MXPA05001558A
(es)
*
|
2002-08-12 |
2005-09-08 |
Pharmacia & Upjohn Co Llc |
N-aril-2-oxazolidinonas y sus derivados.
|
US20070167414A1
(en)
*
|
2002-08-22 |
2007-07-19 |
Orchid Chemicals & Pharmaceuticals Limited |
Novel antibacterial agents
|
EP1578734A1
(en)
*
|
2002-08-22 |
2005-09-28 |
Orchid Chemicals and Pharmaceuticals Ltd |
Novel antibacterial agents
|
AU2002339721A1
(en)
|
2002-09-20 |
2004-04-08 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US6875784B2
(en)
|
2002-10-09 |
2005-04-05 |
Pharmacia & Upjohn Company |
Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
|
CA2499105A1
(en)
*
|
2002-10-10 |
2004-04-22 |
Pharmacia & Upjohn Company Llc |
Antimicrobial 1-aryl dihydropyridone compounds
|
BR0316483A
(pt)
*
|
2002-11-21 |
2005-10-11 |
Upjohn Co |
Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
|
AU2002357561A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Nanjing Chang'ao Pharmaceutical Science And Technology Limited Company |
Oxazolidine derivative, methods of preparation and uses
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
JP2006516989A
(ja)
*
|
2003-02-07 |
2006-07-13 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
抗菌剤として使用するための二環式環によりn−置換されたオキサゾリジノン誘導体
|
EP1594865A2
(en)
*
|
2003-02-07 |
2005-11-16 |
Warner-Lambert Company LLC |
Antibacterial agents
|
US20040204463A1
(en)
*
|
2003-04-01 |
2004-10-14 |
Harris Christina Renee |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
US20080214565A1
(en)
*
|
2003-04-07 |
2008-09-04 |
Anita Mehta |
Oxazolidinone Derivatives as Antimicrobials
|
WO2004113329A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
WO2005019214A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Warner-Lambert Company Llc |
Novel antimicrobial aryloxazolidinone compounds
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
US7304050B2
(en)
*
|
2003-09-16 |
2007-12-04 |
Pfizer Inc. |
Antibacterial agents
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
WO2005051933A1
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
WO2005113520A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Pharmacia & Upjohn Company Llc |
Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
|
CA2572054A1
(en)
*
|
2004-06-29 |
2006-01-12 |
Teva Pharmaceutical Industries Ltd. |
Crystalline form iv of linezolid
|
EP1802613A1
(en)
*
|
2004-10-11 |
2007-07-04 |
Ranbaxy Laboratories Limited |
Substituted oxazolidinone derivatives
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
US7291614B2
(en)
*
|
2005-02-24 |
2007-11-06 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of linezolid intermediate
|
EP1874782A1
(en)
|
2005-04-15 |
2008-01-09 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
ATE449773T1
(de)
|
2005-06-29 |
2009-12-15 |
Pharmacia & Upjohn Co Llc |
Homomorpholinoxazolidinone als antibakterielle mittel
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
ATE502937T1
(de)
|
2005-10-04 |
2011-04-15 |
Bayer Schering Pharma Ag |
Neue polymorphe form von 5-chlor-n-(ä ( 5s )-2- 0x0-3-ä4-( 3-oxo-4-morpholinyl)-phenylü-1,3- oxazolidin-5-ylü -methyl)-2-thiophencarboxamid
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
WO2008010070A2
(en)
*
|
2006-07-19 |
2008-01-24 |
Orchid Research Laboratories Limited |
Novel oxazolidinone derivatives
|
US7593630B2
(en)
|
2006-07-24 |
2009-09-22 |
Foxconn Technology Co., Ltd. |
Built-in multidriver device for a camera zoom lens
|
WO2008143649A2
(en)
*
|
2006-12-04 |
2008-11-27 |
Dr. Reddy's Laboratories Limited |
Novel oxazolidinone compounds as antiinfective agents
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
WO2009032294A2
(en)
*
|
2007-09-06 |
2009-03-12 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of a linezolid intermediate, linezolid hydroxide
|
BRPI0909028A2
(pt)
*
|
2008-03-26 |
2015-09-22 |
Global Alliance For Tb Drug Dev |
nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos
|
EP2138178A1
(en)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
|
EP2140866A1
(en)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
|
ES2748505T3
(es)
|
2008-10-10 |
2020-03-17 |
Merck Sharp & Dohme |
Métodos para la preparación de oxazolidinonas y composiciones que las contienen
|
AU2009310952B2
(en)
*
|
2008-10-27 |
2015-04-30 |
Mitsubishi Tanabe Pharma Corporation |
Novel amide derivative and use thereof as medicine
|
US8841306B2
(en)
|
2008-11-20 |
2014-09-23 |
Panacea Biotec Ltd. |
Antimicrobials
|
NZ712289A
(en)
|
2009-02-03 |
2017-03-31 |
Merck Sharp & Dohme |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
CN103360379B
(zh)
*
|
2012-03-31 |
2017-05-24 |
南京圣和药业股份有限公司 |
噁唑烷酮化合物
|
US10995097B2
(en)
|
2016-03-11 |
2021-05-04 |
The Board Of Trustees Of The University Of Illinois |
Small molecules active against gram-negative bacteria
|
US11274106B2
(en)
|
2017-06-23 |
2022-03-15 |
The Board Of Trustees Of The University Of Illinois |
Topoisomerase inhibitors with antibacterial and anticancer activity
|
CN112543756A
(zh)
|
2018-07-25 |
2021-03-23 |
卡迪拉保健有限公司 |
用于治疗哺乳动物感染的经取代噁唑烷酮类
|
CN110372624A
(zh)
*
|
2019-08-13 |
2019-10-25 |
北京海美桐医药科技有限公司 |
一种噁唑烷酮类化合物、其制备方法及应用
|
WO2021184339A1
(en)
*
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|
WO2024069378A1
(en)
*
|
2022-09-26 |
2024-04-04 |
Zydus Lifesciences Limited |
Novel compounds for the treatment of mammalian infections
|